Biosimilars are a sub-category of biologic medicines5. They are follow-on or alternative versions of existing, originator or reference biologic medicines whose marketing exclusivity rights have expired5. To be granted approval as a biosimilar by regulatory authorities, the product must undergo rigorous comparability analyses to prove it possesses similar quality, efficacy and safety to the reference … Continue reading What Is A ‘Biosimilar’?